IQ MPS
IQ Microphysiological Systems Affiliate
An Affiliate of the International Consortium for Innovation and Quality in Drug Development
Agenda
Coming soon.
Moderators and Presenters
Diane Ramsden
Director, Oncology DMPK
AstraZeneca
Diane Ramsden is a Director in Oncology DMPK within AstraZeneca. She has ~20 years experience in industry and is currently responsible for representing drug metabolism and pharmacokinetics (DMPK) on program teams and for leading the ADME group. Her research interests include the application of in vitro and in vivo models towards developing a mechanistic understanding of the disposition of novel therapeutics.
David Stresser, Ph.D.
Senior Principal Research Scientist
AbbVie
David Stresser is a Senior Principal Research Scientist in the DMPK-BA department at AbbVie and leads a team of ADME scientists focusing on investigations of small molecule clearance, plasma protein binding and drug-drug interactions using conventional and complex in vitro models. He is an active participant in various pharma consortia including the IQ Microphysiological Systems Affiliate.
Maarten Huisman
Director, Quantitative Pharmacology and DMPK
UCB Pharma
Maarten Huisman is a seasoned translational scientist with a Ph.D. in Pharmaceutical Sciences from Utrecht University and a MSc in Biology: Molecular and Medical Genetics from the University of Groningen. He currently serves as the DMPK Lead at UCB, focusing on the discovery and development of novel protein degraders, ASO-conjugates, and antibodies.
Before UCB, Maarten held various roles at 3D-PharmXchange, Oystershell Laboratories (Medical Devices), and 2 Bridge CVBA, and contributed significantly at The Janssen Pharmaceutical Companies of Johnson & Johnson. He's adept in strategic planning, project leadership, and embracing new technologies for drug development. His expertise spans several therapeutic areas including oncology, dermatology, immunology, diabetes, and CNS.
Carmen Pin
Senior Director
AstraZeneca
Dr. Carmen Pin is a modeler at AstraZeneca (Cambridge, UK). Prior to joining AstraZeneca, she led the Computational Gastrointestinal Biology Group at the Quadram IB (Norwich, UK). She has co-authored numerous scientific articles and led several substantial scientific research projects.